PRADEEP KUMAR

About

Dr. Pradeep Kumar is currently working as Assistant Professor at Department of Pharmaceutical Sciences and Natural Products, Central University of Punjab, Bathinda, India from July 2015. He has >10 years of teaching and research experience in the field of Pharmaceutical Sciences. He has published >60 research and review articles in journals of international repute with average journal impact factor >3. His publications have been cited >1800 times and has h-index 20 and i10-index 39.

Employment

• Central University of Punjab ASSISTANT PROFESSOR
  2015 - Present
• Doon Valley Institute of Pharmacy and Medicine Assistant Professor
  2013 - 2015
• PDM School of Pharmacy Assistant Professor
  2008 - 2009

Education

• Maharshi Dayanand University Rohtak Ph.D.
  2009 - 2013
• Guru Jambheshwar University of Science and Technology B. Pharm.
  2002 - 2006

Projects & Funding

Projects & funding information is unavailable.

Publications (89)

• Design, Synthesis, and Anticancer Assessment of Benzylated Pyrrole‐Based Pyrido[2,3‐d]Pyrimidines as Thymidylate Synthase Inhibitors
  Chemical Biology & Drug Design 2026 DOI: 10.1111/cbdd.70240
  +Save
• Thioxo-tetrahydro-pyrimidin-benzenesulfonamide hybrids as potential BRAFV600E inhibitors: experimental, computational and biological evaluations
  Journal of Molecular Structure 2026 DOI: 10.1016/j.molstruc.2025.143620
  +Save
• Unrevealing the Multifaceted Role of Resveratrol as Potential Antioxidant and Anticancer Agent: Molecular Mechanism and Future Perspectives
  Chemistry & Biodiversity 2026 DOI: 10.1002/cbdv.202403280
  +Save
• Medicinal Chemistry Perspective of 1,8‐Naphthyridines as Anticancer Agents
  Chemistry & Biodiversity 2025 DOI: 10.1002/cbdv.202501396
  +Save
• Synthesis and anticancer evaluation of novel pyrrole-pyrido[2,3-d] pyrimidine-based compounds as thymidylate synthase inhibitors
  Journal of Molecular Structure 2025 DOI: 10.1016/j.molstruc.2025.142053
  +Save
• Structural insights, regulation, and recent advances of RAS inhibitors in the MAPK signaling cascade: a medicinal chemistry perspective
  RSC Medicinal Chemistry 2025 DOI: 10.1039/D4MD00923A
  +Save
• Medicinal chemistry aspects of uracil containing dUTPase inhibitors targeting colorectal cancer
  Drug Discovery Today 2024 DOI: 10.1016/j.drudis.2023.103853
  +Save
• Semisynthetic phytochemicals in cancer treatment: a medicinal chemistry perspective
  RSC Medicinal Chemistry 2024 DOI: 10.1039/D4MD00317A
  +Save
• Current insights and molecular docking studies of HIV‐1 reverse transcriptase inhibitors
  Chemical Biology & Drug Design 2024 DOI: 10.1111/cbdd.14372
  +Save
• Synthesis and Anticancer Evaluation of Benzylated Indole Based Alkyl‐Substituted Pyrido[2,3‐d]Pyrimidines Targeting Thymidylate Synthase
  ChemistrySelect 2024 DOI: 10.1002/slct.202400249
  +Save